Stay updated on Lanadelumab in Preventing Angioedema Attacks Clinical Trial
Sign up to get notified when there's something new on the Lanadelumab in Preventing Angioedema Attacks Clinical Trial page.

Latest updates to the Lanadelumab in Preventing Angioedema Attacks Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedA new revision entry v3.6.3 was added to the record history and the previous v3.6.2 entry was removed, updating the page's version history.SummaryDifference0.1%

- Check27 days agoChange DetectedThe revision tag for the page has been updated from v3.6.0 to v3.6.2, indicating a new version of the record history page.SummaryDifference0.1%

- Check42 days agoChange DetectedThe history now notes that recruitment is closed ('No longer looking for participants') and the revision tag has been updated to v3.6.0, replacing the previous v3.5.5.SummaryDifference0.4%

- Check49 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5 in the page history, signaling a new revision of the record. It represents a metadata version change rather than altering study data or content.SummaryDifference0.1%

- Check70 days agoChange DetectedThe page’s revision tag was updated from v3.5.3 to v3.5.4, indicating a new release version in the history. This update does not change the underlying study content.SummaryDifference0.1%

- Check91 days agoChange DetectedThe page’s revision/version indicator has been updated from v3.5.2 to v3.5.3, reflecting a site release rather than a change to the trial record content.SummaryDifference0.1%

Stay in the know with updates to Lanadelumab in Preventing Angioedema Attacks Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lanadelumab in Preventing Angioedema Attacks Clinical Trial page.